Aclaris Therapeutics Vs. NICE Industry Stock Comparison

Sell

22

ACRS
Aclaris Therapeutics

Last Price:

1.13

Seasonality Move:

-8.1%

Sell

39

NICE
NICE

Last Price:

167.13

Seasonality Move:

6.43%

Sell

22

Aclaris Therapeutics (ACRS) is a Sell

Is Aclaris Therapeutics a Buy, Sell or Hold?

The current Aclaris Therapeutics [ACRS] share price is $1.13. The Score for ACRS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
ACRS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

39

NICE (NICE) is a Sell

Is NICE a Buy, Sell or Hold?

The current NICE [NICE] share price is $167.06. The Score for NICE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
NICE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ACRS Stock Price Chart

What is Aclaris Therapeutics's stock price today?

The Aclaris Therapeutics share price today is $1.13
The current trend is relatively stagnant and ACRS is experiencing slight selling pressure.

NICE Stock Price Chart

What is NICE's stock price today?

The NICE share price today is $167.06
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NICE is experiencing slight buying pressure.

ACRS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.01	Sell
Relative Strength Index (14 RSI):	50.43	Buy
Chaikin Money Flow:	-214047	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.04 - 1.18)	Buy
Bollinger Bands (100):	(1.11 - 1.27)	Sell

NICE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-12.05	Sell
Relative Strength Index (14 RSI):	28.08	Sell
Chaikin Money Flow:	136161	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(168.62 - 205.34)	Sell
Bollinger Bands (100):	(196.7 - 247)	Sell

ACRS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.11	Buy
20-day SMA:	1.1	Buy
50-day SMA:	1.17	Sell
200-day SMA:	2.42	Sell
8-day EMA:	1.12	Buy
20-day EMA:	1.12	Buy
50-day EMA:	1.16	Sell
200-day EMA:	2.9	Sell

NICE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	170.62	Sell
20-day SMA:	180.24	Sell
50-day SMA:	207.71	Sell
200-day SMA:	202.95	Sell
8-day EMA:	171.08	Sell
20-day EMA:	181.17	Sell
50-day EMA:	200.17	Sell
200-day EMA:	208.96	Sell

Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.04 per share, an increase this year of $0.86 per share, and an increase next year of $0.23 per share.

NICE Earnings Growth & NICE Earnings Dates

Analysts estimate an earnings increase this quarter of $0.54 per share, an increase next quarter of $0.25 per share, an increase this year of $1.95 per share, and an increase next year of $1.50 per share.

Aclaris Therapeutics Technical Analysis

	Jun 4	Jun 5	Jun 6	Jun 7	Jun 10	Jun 11	Jun 12	Jun 13	Jun 14	Jun 17
	Jun
	04	05	06	07	10	11	12	13	14	17
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NICE Technical Analysis

	Jun 4	Jun 5	Jun 6	Jun 7	Jun 10	Jun 11	Jun 12	Jun 13	Jun 14	Jun 17
	Jun
	04	05	06	07	10	11	12	13	14	17
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):